Fig. 1

(a) Venn diagram on silibinin targets and DEGs associated with HNSCC. (b) Correlation between GSVA score and cancer-related pathway activity in HNC. (c–f) Show the GO and KEGG enrichment analysis. (c) Top ten significant biological process (BP) entries. (d) Top ten significant cell component (CC) entries. (e) Top ten significant molecular function (MF) entries. (f) KEGG enrichment analysis for therapeutic targets, the image is sourced from www.kegg.jp/kegg/kegg1.html. (*P < 0.05; #FDR ≤ 0.05)